Motley Fool Asset Management LLC
Position in AXSM — Axsome Therapeutics, Inc.
CIK 1512814
ALEXANDRIA, VA
Position in AXSM
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$379,638
New position
Shares Held
1,551
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#350
of 503 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Motley Fool Asset Management LLC holds $16,682,515 across 10 Biotechnology names. AXSM ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,288 | $8,587,468 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,170 | $2,760,445 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
70,651 | $2,359,036 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
91,041 | $762,013 | |
| 5 | EXEL |
Exelixis, Inc.
|
8,708 | $473,802 | |
| 6 | MRNA |
Moderna, Inc.
|
6,721 | $470,671 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
This page
|
1,551 | $379,638 | |
| 8 | INCY |
Incyte Corp
|
3,291 | $373,067 |
All Filings in AXSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $379,638 | 1,551 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||